Clough Global Equity Fund

Holdings as of 09/30/2017, subject to change

Common Stock
Description % of Total Portfolio
Liberty Ventures 3.03%
Citigroup, Inc. 2.59%
Starwood Property Trust, Inc. 2.53%
Bank of America Corp. 2.49%
Broadcom, Ltd. 2.40%
Ares Capital Corp. 2.30%
Lam Research Corp. 2.28%
Blackstone Mortgage Trust, Inc. 2.19%
Alibaba Group Holding, Ltd. 2.09%
Liberty Broadband Corp. 2.01%
Facebook, Inc. 1.91%
Apple, Inc. 1.79%
Samsung Electronics Co., Ltd. 1.70%
Yelp, Inc. 1.68%
DR Horton, Inc. 1.51%
Eversource Energy 1.48%
Dominion Energy, Inc. 1.46%
Microsoft Corp. 1.41%
JPMorgan Chase & Co. 1.35%
Merck & Co., Inc. 1.33%
ViaSat, Inc. 1.30%
Express Scripts Holding Co. 1.22%
Cypress Semiconductor Corp. 1.21%
Biogen, Inc. 1.17%
Credit Acceptance Corp. 1.17%
Amazon.com, Inc. 1.15%
LogMeIn, Inc. 1.13%
Boston Scientific Corp. 1.10%
Align Technology, Inc. 1.06%
Golub Capital BDC, Inc. 1.04%
PulteGroup, Inc. 0.98%
Cognizant Technology Solutions Corp. 0.95%
Bristol-Myers Squibb Co. 0.95%
Pfizer, Inc. 0.86%
PennyMac Mortgage Investment Trust 0.86%
Ping An Insurance Group Co. of China, Ltd. - Class H 0.85%
ams AG 0.80%
JD.com, Inc. - ADR 0.79%
Japan Tobacco, Inc. 0.79%
salesforce.com, Inc. 0.79%
National Grid PLC - Sponsored ADR 0.78%
Physicians Realty Trust 0.71%
AMERCO 0.69%
Ladder Capital Corp. 0.67%
Micron Technology, Inc. 0.66%
Galapagos NV 0.65%
Solar Capital, Ltd. 0.63%
Nintendo Co., Ltd. 0.62%
Panasonic Corp. 0.59%
Ctrip.com International, Ltd. 0.58%
Microsemi Corp. 0.58%
Carvana Co. 0.57%
Lennar Corp. 0.56%
Baozun, Inc. 0.55%
Alexion Pharmaceuticals, Inc. 0.54%
zooplus AG 0.51%
Celgene Corp. 0.49%
Sony Corp. 0.49%
Sienna Biopharmaceuticals - Series B - 144A 0.49%
Altice USA, Inc. 0.49%
Bioverativ, Inc. 0.48%
Ellie Mae, Inc. 0.46%
Vertex Pharmaceuticals, Inc. 0.46%
Ulvac, Inc. 0.45%
Intra-Cellular Therapies, Inc. 0.45%
GW Pharmaceuticals PLC 0.42%
Arbor Realty Trust, Inc. 0.42%
Service Corp. International 0.42%
Byd Co., Ltd. - Class H 0.42%
Chr Hansen Holding A/S 0.40%
Fairway Energy LP - 144A 0.39%
CRISPR Therapeutics AG - Series B 0.37%
Community Healthcare Trust, Inc. 0.37%
TRI Pointe Group, Inc. 0.35%
Hologic, Inc. 0.35%
Sienna Biopharmaceuticals, Inc. 0.35%
CRISPR Therapeutics AG 0.33%
Baidu, Inc. 0.33%
Global Medical REIT, Inc. 0.32%
Franklin Resources, Inc. 0.32%
TPG Specialty Lending, Inc. 0.31%
BioMarin Pharmaceutical, Inc. 0.31%
Goldman Sachs BDC, Inc. 0.30%
Cardiome Pharma Corp. 0.26%
Clovis Oncology, Inc. 0.26%
Pacira Pharmaceuticals, Inc. 0.25%
Man Wah Holdings, Ltd. 0.16%
Dermira, Inc. 0.12%
Apellis Pharmaceutical - Pp - 144A 0.09%
Total Common Stock 81.47%
Other Financial Instruments
Description % of Total Portfolio
Total Return Swaps Contracts 6.58%
Foreign Currency 2.85%
Securities Sold Short -9.60%
Total Other Financial Instruments -0.17%
Asset/Mortgage Backed Securities
Description % of Total Portfolio
Government National Mortgage Association - REMICS
10/16/2040, 2.337%
0.27%
Total Asset/Mortgage Backed Securities 0.27%
Short-Term Investments
Description % of Total Portfolio
BlackRock Liquidity Funds, T-Fund Portfolio - Institutional Class
12/31/2049, 0.887%
9.84%
Total Short-Term Investments 9.84%
Government & Agency Obligations
Description % of Total Portfolio
U.S. Treasury Bonds
08/15/2029, 6.125%
1.85%
U.S. Treasury Bonds
02/15/2018, 3.500%
1.19%
U.S. Treasury Bonds
11/15/2026, 6.500%
0.64%
Total Government & Agency Obligations 3.68%
Participation Notes
Description % of Total Portfolio
Midea Group Co., Ltd. - 144A
05/13/2019
0.91%
Kweichow Moutai Co., Ltd. - 144A
11/09/2017
0.34%
Total Participation Notes 1.25%
Mutual Fund
Description % of Total Portfolio
Altaba, Inc. 1.18%
Total Mutual Fund 1.18%
Preferred Stock
Description % of Total Portfolio
Annaly Capital Management, Inc., 7.625% 1.09%
Ares Management LP, 7.000% 0.57%
Two Harbors Investment Corp., 0.000% 0.41%
PennyMac Mortgage Investment Trust, 0.000% 0.21%
Global Medical REIT, Inc.
12/31/2049, 7.500%
0.13%
PennyMac Mortgage Investment Trust, 0.000% 0.07%
Total Preferred Stock 2.48%

1Only individual long positions shown.

According to the Fund's holding disclosure policy, as approved by the Board of Trustees, the release of the month-end holdings information will be delayed at least 30 days.

Holdings subject to change without notice.